JWA
IRWD icon

JFS Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

JFS Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$66 – 1991
2024
Q2 		$66 Sell
10
-83
-89% -$587 ﹤0.01% 1946
2024
Q1 		$811 Hold
93
– – ﹤0.01% 1703
2023
Q4 		$1.06K Buy
93
+83
+830% +$821 ﹤0.01% 1646
2023
Q3 		$97 Sell
10
-65
-87% -$637 ﹤0.01% 1907
2023
Q2 		$798 Hold
75
– – ﹤0.01% 1666
2023
Q1 		$789 Sell
75
-2
-3% -$22 ﹤0.01% 1639
2022
Q4 		$954 Buy
77
+41
+114% +$465 ﹤0.01% 1616
2022
Q3 		$0 Sell
36
-44
-55% -$499 ﹤0.01% 1819
2022
Q2 		$1K Buy
80
+20
+33% +$236 ﹤0.01% 1550
2022
Q1 		$1K Buy
60
+34
+131% +$390 ﹤0.01% 1657
2021
Q4 		$0 Buy
+26
New +$319 ﹤0.01% 1792

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JFS Wealth Advisors's IRWD Position: Q3 2024 in Review

JFS Wealth Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 10 shares — an estimated $66 sold.

JFS Wealth Advisors first reported a position in IRWD in Q4 2021 and held it in 11 quarters. The position peaked at $1.06K in Q4 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • JFS Wealth Advisors reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • JFS Wealth Advisors sold 10 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $66.
  • JFS Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 11 quarters.
  • JFS Wealth Advisors's Ironwood Pharmaceuticals position peaked at $1.06K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on JFS Wealth Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.